Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients.

This Congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.